drugset / Trial / NCT06756074
Reinforced Pancreaticojejunostomy With or Without glubran2
RandomizedParallel-groupDouble-blindTreatment
Summary
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Timeline
- Start
- 2025-01-15
- Primary completion
- 2026-04-15
- Completion
- 2026-05-15
Outcome
Met primary endpoint
paper POPF (Grade B/C) occurred in 3 patients (6%) in the Glubran®2 group versus 11 patients (22%) in the Control group (p = 0.041; Fisher's exact test). PMID 42381068 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glubran®2 | Unknown | — | — |